These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18538437)

  • 1. Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis.
    Hwang SM; Kim DD; Chung SJ; Shim CK
    J Control Release; 2008 Jul; 129(2):100-6. PubMed ID: 18538437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan microspheres as an alveolar macrophage delivery system of ofloxacin via pulmonary inhalation.
    Park JH; Jin HE; Kim DD; Chung SJ; Shim WS; Shim CK
    Int J Pharm; 2013 Jan; 441(1-2):562-9. PubMed ID: 23142421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ofloxacin targeting to lungs by way of microspheres.
    Harsha S; R C; Rani S
    Int J Pharm; 2009 Oct; 380(1-2):127-32. PubMed ID: 19646516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High azithromycin loading powders for inhalation and their in vivo evaluation in rats.
    Zhang Y; Wang X; Lin X; Liu X; Tian B; Tang X
    Int J Pharm; 2010 Aug; 395(1-2):205-14. PubMed ID: 20595022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targeting to lungs by way of microspheres.
    Harsha NS; Rani RH
    Arch Pharm Res; 2006 Jul; 29(7):598-604. PubMed ID: 16903082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis.
    Hirota K; Hasegawa T; Nakajima T; Inagawa H; Kohchi C; Soma G; Makino K; Terada H
    J Control Release; 2010 Mar; 142(3):339-46. PubMed ID: 19951729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G; Vanderbist F; Amighi K
    Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
    Tewes F; Brillault J; Couet W; Olivier JC
    J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-based drug delivery to alveolar macrophages.
    Vyas SP; Khatri K
    Expert Opin Drug Deliv; 2007 Mar; 4(2):95-9. PubMed ID: 17335407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristics.
    Dellamary L; Smith DJ; Bloom A; Bot S; Guo GR; Deshmuk H; Costello M; Bot A
    J Control Release; 2004 Mar; 95(3):489-500. PubMed ID: 15023460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticles of rifampicin: comparison of pulmonary route with oral route for drug uptake by alveolar macrophages, phagocytosis activity and toxicity study in albino rats.
    Parikh R; Patel L; Dalwadi S
    Drug Deliv; 2014 Sep; 21(6):406-11. PubMed ID: 24215141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY; Wang CH
    J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    Pharm Dev Technol; 2013; 18(6):1361-5. PubMed ID: 22812381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride.
    Huh Y; Cho HJ; Yoon IS; Choi MK; Kim JS; Oh E; Chung SJ; Shim CK; Kim DD
    Eur J Pharm Sci; 2010 Apr; 40(1):9-15. PubMed ID: 20149868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin-palladium complex.
    Palazzo F; Giovagnoli S; Schoubben A; Blasi P; Rossi C; Ricci M
    Int J Pharm; 2013 Jan; 440(2):273-82. PubMed ID: 22659124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of lung targeting azithromycin liposomes and its tissue distribution in mice].
    Wang JS; Zhu JB; Lu RQ; Shen W
    Yao Xue Xue Bao; 2005 Mar; 40(3):274-8. PubMed ID: 15952603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology.
    Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Mirzadeh H; Fakhari A; Nokhodchi A
    J Microencapsul; 2009 Feb; 26(1):1-8. PubMed ID: 18465287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.